Cerebrovascular complications of diabetes: Focus on stroke

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 12, Issue 2, 2012, Pages 148-158

  Ergul, Adviye ^a   Kelly Cobbs, Aisha ^a   Abdalla, Maha ^a   Fagan, Susan C ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Cerebral vasculature; Diabetes; Hemorrhage; Ischemia; Stroke; Targets

Indexed keywords

PROTEINASE;

ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE; DIABETES MELLITUS; EDEMA; HUMAN; MORBIDITY; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PROTEIN EXPRESSION; REPERFUSION INJURY; RISK FACTOR; STROKE;

ANIMALS; CEREBRUM; DIABETIC ANGIOPATHIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPERTENSION; HYPOGLYCEMIC AGENTS; MALE; MICE; RATS; RISK; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84861131729     PISSN: 18715303     EISSN: 22123873     Source Type: Journal    
DOI: 10.2174/187153012800493477     Document Type: Article

References (116)

1. Association, A. D. National diabetes fact sheet.
2. Ehehalt, S.; Blumenstock, G.; Willasch, A. M.; Hub, R.; Ranke, M. B. and Neu, A. (2008) Continuous rise in incidence of childhood Type 1 diabetes in Germany. Diabet. Med., 25, (6), 755-757.
3. Kumar, P.; Krishna, P.; Reddy, S. C.; Gurappa, M.; Aravind, S. R. and Munichoodappa, C. (2008) Incidence of type 1 diabetes mellitus and associated complications among children and young adults: results from Karnataka Diabetes Registry 1995-2008. J. Indian. Med. Assoc., 106(11), 708-711.
4. Variation and trends in incidence of childhood diabetes in Europe. (2000) EURODIAB ACE Study Group. Lancet, 355(9207), 873-876.
5. Ergul, A.; Li, W.; Elgebaly, M. M.; Bruno, A. and Fagan, S. C. (2009) Hyperglycemia, diabetes and stroke: Focus on the cerebrovasculature. Vascul. Pharmacol., 51, 44-49.
6. McCormick, M. T.; Muir, K. W.; Gray, C. S. and Walters, M. R. (2008) Management of hyperglycemia in acute stroke: how, when, and for whom? Stroke, 39(7), 2177-2185.
7. Huber, J. D. (2008) Diabetes, cognitive function, and the bloodbrain barrier. Curr. Pharm. Des., 14(16), 1594-1600.
8. Sima, A. A. (2010) Encephalopathies: the emerging diabetic complications. Acta. Diabetol., 47(4), 279-293.
9. Stiles, M. C. and Seaquist, E. R. (2010) Cerebral structural and functional changes in type 1 diabetes. Minerva Med., 101(2), 105-114.
10. Kodl, C. T.; Franc, D. T.; Rao, J. P.; Anderson, F. S.; Thomas, W.; Mueller, B. A.; Lim, K. O. and Seaquist, E. R. (2008) Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function. Diabetes, 57(11), 3083-3089.
11. Kodl, C. T. and Seaquist, E. R. (2008) Cognitive dysfunction and diabetes mellitus. Endocr. Rev., 29(4), 494-511.
12. Laing, S. P.; Swerdlow, A. J.; Carpenter, L. M.; Slater, S. D.; Burden, A. C.; Botha, J. L.; Morris, A. D.; Waugh, N. R.; Gatling, W.; Gale, E. A.; Patterson, C. C.; Qiao, Z. and Keen, H. (2003) Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin-treated diabetes. Stroke, 34(2), 418-421.
13. Janghorbani, M.; Hu, F. B.; Willett, W. C.; Li, T. Y.; Manson, J. E.; Logroscino, G. and Rexrode, K. M. (2007) Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses' Health Study. Diabetes Care, 30(7), 1730-1735.
14. Sundquist, K. and Li, X. (2006) Type 1 diabetes as a risk factor for stroke in men and women aged 15-49: a nationwide study from Sweden. Diabet. Med., 23(11), 1261-1267.
15. Almdal, T.; Scharling, H.; Jensen, J. S. and Vestergaard, H. (2004) The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch. Intern. Med., 164(13), 1422-1426.
16. Jeerakathil, T.; Johnson, J. A.; Simpson, S. H. and Majumdar, S. R. (2007) Short-term risk for stroke is doubled in persons with newly treated type 2 diabetes compared with persons without diabetes: a population-based cohort study. Stroke, 38(6), 1739-1743.
17. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). (1998) UK Prospective Diabetes Study (UKPDS) Group. Lancet, 352(9131), 837-853.
18. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). (1998) UK Prospective Diabetes Study (UKPDS) Group. Lancet, 352(9131), 854-865.
19. Gerstein, H. C.; Miller, M. E.; Byington, R. P.; Goff, D. C. Jr.; Bigger, J. T.; Buse, J. B.; Cushman, W. C.; Genuth, S.; Ismail-Beigi, F.; Grimm, R. H. Jr.; Probstfield, J. L.; Simons-Morton, D. G. and Friedewald, W. T. (2008) Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med., 358(24), 2545-2559.
20. Patel, A.; MacMahon, S.; Chalmers, J.; Neal, B.; Billot, L.; Woodward, M.; Marre, M.; Cooper, M.; Glasziou, P.; Grobbee, D.; Hamet, P.; Harrap, S.; Heller, S.; Liu, L.; Mancia, G.; Mogensen, C. E.; Pan, C.; Poulter, N.; Rodgers, A.; Williams, B.; Bompoint, S.; de Galan, B. E.; Joshi, R. and Travert, F. (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med., 358(24), 2560-7252.
21. Duckworth, W.; Abraira, C.; Moritz, T.; Reda, D.; Emanuele, N.; Reaven, P. D.; Zieve, F. J.; Marks, J.; Davis, S. N.; Hayward, R.; Warren, S. R.; Goldman, S.; McCarren, M.; Vitek, M. E.; Henderson, W. G. and Huang, G. D. (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med., 360(2), 129-139.
22. Nathan, D. M.; Cleary, P. A.; Backlund, J. Y.; Genuth, S. M.; Lachin, J. M.; Orchard, T. J.; Raskin, P. and Zinman, B. (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med., 353(25), 2643-2653.
23. Hu, G.; Sarti, C.; Jousilahti, P.; Peltonen, M.; Qiao, Q.; Antikainen, R. and Tuomilehto, J. (2005) The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality. Stroke, 36(12), 2538-2543.
24. Cushman, W. C.; Evans, G. W.; Byington, R. P.; Goff, D. C. Jr.; Grimm, R. H. Jr.; Cutler, J. A.; Simons-Morton, D. G.; Basile, J. N.; Corson, M. A.; Probstfield, J. L.; Katz, L.; Peterson, K. A.; Friedewald, W. T.; Buse, J. B.; Bigger, J. T.; Gerstein, H. C. and Ismail-Beigi, F. (2010) Effects of intensive blood-pressure control in type 2 diabetes mellitus. N. Engl. J. Med., 362(17), 1575-1585.
25. Colhoun, H. M.; Betteridge, D. J.; Durrington, P. N.; Hitman, G. A.; Neil, H. A.; Livingstone, S. J.; Thomason, M. J.; Mackness, M. I.; Charlton-Menys, V. and Fuller, J. H. (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet, 364(9435), 685-696.
26. Collins, R.; Armitage, J.; Parish, S.; Sleigh, P. and Peto, R. (2003) MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebocontrolled trial. Lancet, 361(9374), 2005-2016.
27. Ginsberg, H. N.; Elam, M. B.; Lovato, L. C.; Crouse, J. R.3rd; Leiter, L. A.; Linz, P.; Friedewald, W. T.; Buse, J. B.; Gerstein, H. C.; Probstfield, J.; Grimm, R. H.; Ismail-Beigi, F.; Bigger, J. T.; Goff, D. C. Jr.; Cushman, W. C.; Simons-Morton, D. G. and Byington, R. P. (2010) Effects of combination lipid therapy in type 2 diabetes mellitus. N. Engl. J. Med., 362(17), 1563-1574.
28. Scott, J. F.; Robinson, G. M.; French, J. M.; O'Connell, J. E.; Alberti, K. G. and Gray, C. S. (1999) Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. Lancet, 353(9150), 376-377.
29. Lindsberg, P. J. and Roine, R. O. (2004) Hyperglycemia in acute stroke. Stroke, 35(2), 363-364.
30. Capes, S. E.; Hunt, D.; Malmberg, K.; Pathak, P. and Gerstein, H. C. (2001) Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke, 32(10), 2426-2432.
31. Adams, H. P. Jr.; del Zoppo, G.; Alberts, M. J.; Bhatt, D. L.; Brass, L.; Furlan, A.; Grubb, R. L.; Higashida, R. T.; Jauch, E. C.; Kidwell, C.; Lyden, P. D.; Morgenstern, L. B.; Qureshi, A. I.; Rosenwasser, R. H.; Scott, P. A. and Wijdicks, E. F. (2007) Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke, 38(5), 1655-1711.
32. Ntaios, G.; Egli, M.; Faouzi, M. and Michel, P. (2010) J-shaped association between serum glucose and functional outcome in acute ischemic stroke. Stroke, 41(10), 2366-2370.
33. McCormick, M.; Hadley, D.; McLean, J. R.; Macfarlane, J. A.; Condon, B. and Muir, K. W. (2010) Randomized, controlled trial of insulin for acute poststroke hyperglycemia. Ann. Neurol., 67(5), 570-578.
34. Demchuk, A. M.; Morgenstern, L. B.; Krieger, D. W.; Linda Chi, T.; Hu, W.; Wein, T. H.; Hardy, R. J.; Grotta, J. C. and Buchan, A. M. (1999) Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke, 30(1), 34-39.
35. Kase, C. S.; Furlan, A. J.; Wechsler, L. R.; Higashida, R. T.; Rowley, H. A.; Hart, R. G.; Molinari, G. F.; Frederick, L. S.; Roberts, H. C.; Gebel, J. M.; Sila, C. A.; Schulz, G. A.; Roberts, R. S. and Gent, M. (2001) Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology, 57(9), 1603-1610.
36. Bruno, A.; Levine, S. R.; Frankel, M. R.; Brott, T. G.; Lin, Y.; Tilley, B. C.; Lyden, P. D.; Broderick, J. P.; Kwiatkowski, T. G. and Fineberg, S. E. (2002) Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology, 59(5), 669-674.
37. Poppe, A. Y.; Majumdar, S. R.; Jeerakathil, T.; Ghali, W.; Buchan, A. M. and Hill, M. D. (2009) Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes Care, 32(4), 617-622.
38. Alvarez-Sabin, J.; Molina, C. A.; Montaner, J.; Arenillas, J. F.; Huertas, R.; Ribo, M.; Codina, A. and Quintana, M. (2003) Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients. Stroke, 34(5), 1235-1241.
39. Adams, H. P. Jr.; Bendixen, B. H.; Kappelle, L. J.; Biller, J.; Love, B. B.; Gordon, D. L. and Marsh, E. E. 3rd. (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 24(1), 35-41.
40. Bruno, A.; Biller, J.; Adams, H. P. Jr.; Clarke, W. R.; Woolson, R. F.; Williams, L. S. and Hansen, M. D. (1999) Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology, 52(2), 280-284.
41. Tuttolomondo, A.; Pinto, A.; Salemi, G.; Di Raimondo, D.; Di Sciacca, R.; Fernandez, P.; Ragonese, P.; Savettieri, G. and Licata, G. (2008) Diabetic and non-diabetic subjects with ischemic stroke: differences, subtype distribution and outcome. Nutr. Metab. Cardiovasc. Dis., 18(2), 152-157.
42. Bruno, A.; Kent, T. A.; Coull, B. M.; Shankar, R. R.; Saha, C.; Becker, K. J.; Kissela, B. M. and Williams, L. S. (2008) Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke, 39(2), 384-389.
43. Johnston, K. C.; Hall, C. E.; Kissela, B. M.; Bleck, T. P. and Conaway, M. R. (2009) Glucose Regulation in Acute Stroke Patients (GRASP) Trial. A Randomized Pilot Trial. Stroke
44. Putaala, J.; Kurkinen, M.; Tarvos, V.; Salonen, O.; Kaste, M. and Tatlisumak, T. (2009) Silent brain infarcts and leukoaraiosis in young adults with first-ever ischemic stroke. Neurology, 72(21), 1823-1829.
45. Eguchi, K.; Kario, K. and Shimada, K. (2003) Greater impact of coexistence of hypertension and diabetes on silent cerebral infarcts. Stroke, 34(10), 2471-2474.
46. American Heart Association A. H. (2011) Heart and stroke statistical update.
47. Frier, B. M. (2011) Cognitive functioning in type 1 diabetes: the Diabetes Control and Complications Trial (DCCT) revisited. Diabetologia, 54(2), 233-236.
48. Starr, J. M.; Wardlaw, J.; Ferguson, K.; MacLullich, A.; Deary, I. J. and Marshall, I. (2003) Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J. Neurol. Neurosurg. Psychiatry,74(1), 70-76.
49. Derosa, G.; D'Angelo, A.; Tinelli, C.; Devangelio, E.; Consoli, A.; Miccoli, R.; Penno, G.; Del Prato, S.; Paniga, S. and Cicero, A. F. (2007) Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects. Diabetes Metab., 33(2), 129-134.
50. Bohlen, H. G. and Niggl, B. A. (1979) Arteriolar anatomical and functional abnormalities in juvenile mice with genetic or streptozotocin-induced diabetes mellitus. Circ. Res., 45(3), 390-396.
51. Bohlen, H. G. and Niggl, B. A. (1979) Adult microvascular disturbances as a result of juvenile onset diabetes in Db/Db mice. Blood Vessels, 16(5), 269-276.
52. Mayhan, W. G. (1993) Cerebral circulation during diabetes mellitus. Pharmacol. Ther., 57(2-3), 377-391.
53. McCuskey, P. A. and McCuskey, R. S. (1984) In vivo and electron microscopic study of the development of cerebral diabetic microangiography. Microcirc. Endothelium Lymphatics, 1(2), 221-244.
54. Mukai, N.; Hori, S. and Pomeroy, M. (1980) Cerebral lesions in rats with streptozotocin-induced diabetes. Acta Neuropathol., 51(1), 79-84.
55. Tomassoni, D.; Bellagamba, G.; Postacchini, D.; Venarucci, D. and Amenta, F. (2004) Cerebrovascular and brain microanatomy in spontaneously hypertensive rats with streptozotocin-induced diabetes. Clin. Exp. Hypertens., 26(4), 305-321.
56. Moore, S. A.; Bohlen, H. G.; Miller, B. G. and Evan, A. P. (1985) Cellular and vessel wall morphology of cerebral cortical arterioles after short-term diabetes in adult rats. Blood Vessels, 22(6), 265-277.
57. Patton, N.; Aslam, T.; Macgillivray, T.; Pattie, A.; Deary, I. J. and Dhillon, B. (2005) Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J. Anat., 206(4), 319-348.
58. Ergul, A.; Elgebaly, M. M.; Middlemore, M. L.; Li, W.; Elewa, H.; Switzer, J. A.; Hall, C.; Kozak, A. and Fagan, S. C. (2007) Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes. BMC Neurol., 7, 33.
59. Li, W.; Prakash, R.; Kelly-Cobbs, A. I.; Ogbi, S.; Kozak, A.; El-Remessy, A. B.; Schreihofer, D. A.; Fagan, S. C. and Ergul, A. (2010) Adaptive cerebral neovascularization in a model of Type 2 Diabetes: Relevance to focal cerebral ischemia. Diabetes, 59, 228-235.
60. Harris, A. K.; Hutchinson, J. R.; Sachidanandam, K.; Johnson, M. H.; Dorrance, A. M.; Stepp, D. W.; Fagan, S. C. and Ergul, A. (2005) Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1. Diabetes, 54(9), 2638-2644.
61. Kelly-Cobbs, A.; Elgebaly, M. M.; Li, W. and Ergul, A. (2010) Pressure-independent cerebrovascular remodelling and changes in myogenic reactivity in diabetic Goto-Kakizaki rat in response to glycaemic control. Acta. Physiol. (Oxf).
62. Kelly-Cobbs, A. I.; Harris, A. K.; Elgebaly, M. M.; Li, W.; Sachidanandam, K.; Portik-Dobos, V.; Johnson, M. and Ergul, A. (2010) Endothelial EndothelinB receptor-mediated prevention of cerebrovascular remodeling is attenuated in diabetes due to upregulation of smooth muscle endothelin receptors. J. Pharmacol. Exp. Ther., 337(1), 9-15.
63. Ergul, A. (2011) Endothelin-1 and diabetic complications: Focus on the vasculature. Pharmacol. Res., 63(6), 477-482.
64. del Zoppo, G. J. (2006) Stroke and neurovascular protection. N. Engl. J. Med., 354(6), 553-555.
65. del Zoppo, G. J. and Mabuchi, T. Cerebral microvessel responses to focal ischemia. (2003) J. Cereb. Blood. Flow Metab., 23(8), 879-894.
66. Stauber, W. T.; Ong, S. H. and McCuskey, R. S. (1981) Selective extravascular escape of albumin into the cerebral cortex of the diabetic rat. Diabetes, 30(6), 500-503.
67. Hawkins, B. T.; Lundeen, T. F.; Norwood, K. M.; Brooks, H. L. and Egleton, R. D. (2007) Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia, 50(1), 202-211.
68. Chehade, J. M.; Haas, M. J. and Mooradian, A. D. (2002) Diabetesrelated changes in rat cerebral occludin and zonula occludens-1 (ZO-1) expression. Neurochem. Res., 27(3), 249-252.
69. Yuan, S. Y.; Breslin, J. W.; Perrin, R.; Gaudreault, N.; Guo, M.; Kargozaran, H. and Wu, M. H. (2007) Microvascular permeability in diabetes and insulin resistance. Microcirculation, 14(4-5), 363-373.
70. Silvestre, J. S. and Levy, B. I. (2006) Molecular basis of angiopathy in diabetes mellitus. Circ. Res., 98(1), 4-6.
71. Silvestre, J. S.; Levy, B. I. and Tedgui, A. (2008) Mechanisms of angiogenesis and remodelling of the microvasculature. Cardiovasc. Res., 78(2), 201-202.
72. Silvestre, J. S.; Mallat, Z.; Tedgui, A. and Levy, B. I. (2008) Postischaemic neovascularization and inflammation. Cardiovasc. Res., 78(2), 242-249.
73. Caldwell, R. B.; Bartoli, M.; Behzadian, M. A.; El-Remessy, A. E.; Al-Shabrawey, M.; Platt, D. H.; Liou, G. I. and Caldwell, R. W. (2005) Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr. Drug Targets, 6(4), 511-524.
74. Beauquis, J.; Homo-Delarche, F.; Giroix, M. H.; Ehses, J.; Coulaud, J.; Roig, P.; Portha, B.; De Nicola, A. F. and Saravia, F. (2010) Hippocampal neurovascular and hypothalamic-pituitaryadrenal axis alterations in spontaneously type 2 diabetic GK rats. Exp. Neurol., 222(1), 125-134.
75. Arrick, D. M.; Sharpe, G. M.; Sun, H. and Mayhan, W. G. (2007) nNOS-dependent reactivity of cerebral arterioles in Type 1 diabetes. Brain Res., 1184, 365-371.
76. Natali, A.; Toschi, E.; Baldeweg, S.; Ciociaro, D.; Favilla, S.; Sacca, L. and Ferrannini, E. (2006) Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. Diabetes, 55(4), 1133-1140.
77. Didion, S. P.; Lynch, C. M.; Baumbach, G. L. and Faraci, F. M. (2005) Impaired endothelium-dependent responses and enhanced influence of Rho-kinase in cerebral arterioles in type II diabetes. Stroke, 36(2), 342-347.
78. Schwaninger, R. M.; Sun, H. and Mayhan, W. G. (2003) Impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type II diabetic rats. Life Sci., 73(26), 3415-3425.
79. Hogikyan, R. V.; Galecki, A. T.; Pitt, B.; Halter, J. B.; Greene, D. A. and Supiano, M. A. (1998) Specific impairment of endotheliumdependent vasodilation in subjects with type 2 diabetes independent of obesity. J. Clin. Endocrinol. Metab., 83(6), 1946-1952.
80. Erdos, B.; Snipes, J. A.; Tulbert, C. D.; Katakam, P.; Miller, A. W. and Busija, D. W. (2006) Rosuvastatin improves cerebrovascular function in Zucker obese rats by inhibiting NAD(P)H oxidase dependent superoxide production. Am. J. Physiol. Heart Circ. Physiol., 290(3), H1264-H1270.
81. Erdos, B.; Snipes, J. A.; Miller, A. W. and Busija, D. W. (2004) Cerebrovascular dysfunction in Zucker obese rats is mediated by oxidative stress and protein kinase C. Diabetes, 53(5), 1352-1359.
82. Mayhan, W. G.; Arrick, D. M.; Sharpe, G. M.; Patel, K. P. and Sun, H. (2006) Inhibition of NAD(P)H oxidase alleviates impaired NOS-dependent responses of pial arterioles in type 1 diabetes mellitus. Microcirculation, 13(7), 567-575.
83. Trauernicht, A. K.; Sun, H.; Patel, K. P. and Mayhan, W. G. (2003) Enalapril prevents impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in diabetic rats. Stroke, 34(11), 2698-2703.
84. Wang, Y.; Zhang, H. T.; Su, X. L.; Deng, X. L.; Yuan, B. X.; Zhang, W.; Wang, X. F. and Yang, Y. B. (2010) Experimental diabetes mellitus down-regulates large-conductance Ca2+-activated K+ channels in cerebral artery smooth muscle and alters functional conductance. Curr. Neurovasc. Res., 7(2), 75-84.
85. Zimmermann, P. A.; Knot, H. J.; Stevenson, A. S. and Nelson, M. T. (1997) Increased myogenic tone and diminished responsiveness to ATP-sensitive K+ channel openers in cerebral arteries from diabetic rats. Circ. Res., 81(6), 996-1004.
86. Mayhan, W. G.; Mayhan, J. F.; Sun, H. and Patel, K. P. (2004) In vivo properties of potassium channels in cerebral blood vessels during diabetes mellitus. Microcirculation, 11(7), 605-613.
87. Kitayama, J.; Faraci, F. M.; Gunnett, C. A. and Heistad, D. D. (2006) Impairment of dilator responses of cerebral arterioles during diabetes mellitus: role of inducible NO synthase. Stroke, 37(8), 2129-2133.
88. Abiru, T.; Kamata, K.; Miyata, N. and Kasuya, Y. (1990) Differences in vascular responses to vasoactive agents of basilar artery and aorta from rabbits with alloxan-induced diabetes. Can. J. Physiol. Pharmacol., 68(7), 882-888.
89. Mayhan, W. G. (1992) Effect of diabetes mellitus on responses of the basilar artery in rats to products released by platelets. Stroke, 23(10), 1499-1503.
90. Van Buren, T.; Vleeming, W.; Krutzen, M. M.; Van de Kuil, T.; Gispen, W. H. and De Wildt, D. J. (1998) Vascular responses of isolated mesenteric resistance and basilar arteries from short-and long-term diabetic rats. Naunyn Schmiedebergs Arch. Pharmacol., 358(6), 663-670.
91. Mayhan, W. G.; Trauernicht, A. K. and Irvine, S. D. (2001) Insulin reverses impaired acetylcholine-induced dilatation of the rat basilar artery during diabetes mellitus. Brain Res., 893(1-2), 195-201.
92. Mayhan, W. G. (1998) Constrictor responses of the rat basilar artery during diabetes mellitus. Brain Res., 783(2), 326-331.
93. Harris, A. K.; Elgebaly, M. M.; Li, W.; Sachidanandam, K. and Ergul, A. (2008) Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes. Am. J. Physiol. Regul. Integr. Comp. Physiol., 294(4), R1213-R1219.
94. Jarajapu, Y. P.; Guberski, D. L.; Grant, M. B. and Knot, H. J. (2008) Myogenic tone and reactivity of cerebral arteries in type II diabetic BBZDR/Wor rat. Eur. J. Pharmacol., 579(1-3), 298-307.
95. Andersson, D.; Brunkwall, J.; Bergqvist, D. and Edvinsson, L. (1992) Diminished contractile responses to neuropeptide Y of arteries from diabetic rabbits. J. Auton. Nerv. Syst., 37(3), 215-222.
96. Rosenblum, W. I. and Levasseur, J. E. (1984) Microvascular responses of intermediate-size arterioles on the cerebral surface of diabetic mice. Microvasc. Res., 28(3), 368-372.
97. Arrick, D. M.; Sharpe, G. M.; Sun, H. and Mayhan, W. G. (2008) Losartan improves impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type 1 diabetic rats. Brain Res., 1209, 128-135.
98. Arrick, D. M. and Mayhan, W. G. (2010) Inhibition of endothelin-1 receptors improves impaired nitric oxide synthase-dependent dilation of cerebral arterioles in type-1 diabetic rats. Microcirculation, 17(6), 439-446.
99. Martini, S. R. and Kent, T. A. (2007) Hyperglycemia in acute ischemic stroke: a vascular perspective. J. Cereb. Blood. Flow Metab., 27(3), 435-451.
100. Zhang, L.; Nair, A.; Krady, K.; Corpe, C.; Bonneau, R. H.; Simpson, I. A. and Vannucci, S. J. (2004) Estrogen stimulates microglia and brain recovery from hypoxia-ischemia in normoglycemic but not diabetic female mice. J. Clin. Invest., 113(1), 85-95.
101. Kumari, R.; Willing, L. B.; Krady, J. K.; Vannucci, S. J. and Simpson, I. A. (2007) Impaired wound healing after cerebral hypoxia-ischemia in the diabetic mouse. J. Cereb. Blood Flow Metab., 27(4), 710-718.
102. Kumari, R.; Willing, L. B.; Patel, S. D.; Krady, J. K.; Zavadoski, W. J.; Gibbs, E. M.; Vannucci, S. J. and Simpson, I. A. (2010) The PPAR-gamma agonist, darglitazone, restores acute inflammatory responses to cerebral hypoxia-ischemia in the diabetic ob/ob mouse. J. Cereb. Blood Flow Metab., 30(2), 352-360.
103. Vannucci, S. J.; Willing, L. B.; Goto, S.; Alkayed, N. J.; Brucklacher, R. M.; Wood, T. L.; Towfighi, J.; Hurn, P. D. and Simpson, I. A. (2001) Experimental stroke in the female diabetic, db/db, mouse. J. Cereb. Blood Flow Metab., 21(1), 52-60.
104. Li, J. and McCullough, L. D. (2009) Sex differences in minocycline-induced neuroprotection after experimental stroke. J. Cereb. Blood Flow Metab., 29(4), 670-674.
105. Liu, F.; Li, Z.; Li, J.; Siegel, C.; Yuan, R. and McCullough, L. D. (2009) Sex differences in caspase activation after stroke. Stroke, 40(5), 1842-1848.
106. Turtzo, L. C. and McCullough, L. D. (2008) Sex differences in stroke. Cerebrovasc. Dis., 26(5), 462-474.
107. Tureyen, K.; Kapadia, R.; Bowen, K. K.; Satriotomo, I.; Liang, J.; Feinstein, D. L. and Vemuganti, R. (2007) Peroxisome proliferatoractivated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J. Neurochem., 101(1), 41-56.
108. Iwanami, J.; Mogi, M.; Tsukuda, K.; Min, L. J.; Sakata, A.; Jing, F.; Iwai, M. and Horiuchi, M. (2010) Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferatoractivated receptor-gamma activation in diabetic mice. J. Hypertens., 28(8), 1730-1737.
109. Elgebaly, M. M.; Prakash, R.; Li, W.; Ogbi, S.; Johnson, M. H.; Mezzetti, E. M.; Fagan, S. C. and Ergul, A. (2010) Vascular protection in diabetic stroke: role of matrix metalloproteasedependent vascular remodeling. J. Cereb. Blood Flow Metab., 30(12), 1928-1938.
110. Elewa, H. F.; Kozak, A.; El-Remessy, A. B.; Frye, R. F.; Johnson, M. H.; Ergul, A. and Fagan, S. C. (2009) Early atorvastatin reduces hemorrhage after acute cerebral ischemia in diabetic rats. J. Pharmacol. Exp. Ther., 330(2), 532-540.
111. Osmond, J. M.; Mintz, J. D.; Dalton, B. and Stepp, D. W. (2009) Obesity increases blood pressure, cerebral vascular remodeling, and severity of stroke in the Zucker rat. Hypertension, 53(2), 381-386.
112. Rizk, N. N.; Rafols, J. A. and Dunbar, J. C. (2006) Cerebral ischemia-induced apoptosis and necrosis in normal and diabetic rats: effects of insulin and C-peptide. Brain Res., 1096(1), 204-212.
113. Rizk, N. N.; Myatt-Jones, J.; Rafols, J. and Dunbar, J. C. (2007) Insulin like growth factor-1 (IGF-1) decreases ischemia-reperfusion induced apoptosis and necrosis in diabetic rats. Endocrine, 31(1), 66-71.
114. Muranyi, M.; Fujioka, M.; He, Q.; Han, A.; Yong, G.; Csiszar, K. and Li, P. A. (2003) Diabetes activates cell death pathway after transient focal cerebral ischemia. Diabetes, 52(2), 481-486.
115. Liang, W.; Chuan-Zhen, L.; Qiang, D.; Jian, Q.; Hui-Min, R. and Bao-Guo, X. (2004) Reductions in mRNA of the neuroprotective agent, neuroserpin, after cerebral ischemia/reperfusion in diabetic rats. Brain Res., 1015(1-2), 175-180.
116. Kittaka, M.; Wang, L.; Sun, N.; Schreiber, S. S.; Seeds, N. W.; Fisher, M. and Zlokovic, B. V. (1996) Brain capillary tissue plasminogen activator in a diabetes stroke model. Stroke, 27, (4), 712-719.